niacinamide has been researched along with 6-methyl-n-(1h-tetrazol-5-yl)-2-pyridinecarboxamide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, S; Kikuchi, M; Murata, T; Ono, Y; Takeyama, S; Tsuzurahara, K | 1 |
| Date, T; Ishikawa, S; Murata, T; Takeyama, S; Tsuzurahara, K | 1 |
| Hanamoto, K; Hashiyama, T; Honma, Y; Ono, Y; Sekine, Y; Takeda, M; Tsuzurahara, K | 1 |
| Maejima, T; Osawa, T; Yamakita, H | 2 |
| Maejima, T; Matsukawa, Y; Osawa, T; Yamakita, H | 1 |
2 trial(s) available for niacinamide and 6-methyl-n-(1h-tetrazol-5-yl)-2-pyridinecarboxamide
| Article | Year |
|---|---|
In vitro/in vivo evaluation of two series of TA-5707F controlled release matrix tablets prepared with hydroxypropyl methyl cellulose derivatives with entero-soluble or gel-formation properties.
Topics: Adult; Animals; Biotransformation; Delayed-Action Preparations; Dogs; Food; Gels; Histamine H1 Antagonists; Humans; Hypromellose Derivatives; Male; Methylcellulose; Niacinamide; Solubility; Species Specificity; Viscosity | 1995 |
Preparation of controlled release granules of TA-5707F using enteric polymers and ethylcellulose, and their in vivo evaluation.
Topics: Adult; Animals; Anti-Allergic Agents; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dogs; Histamine H1 Antagonists; Humans; Hydrogen-Ion Concentration; Lactose; Male; Methylcellulose; Niacinamide; Oxazines; Solubility; Tablets, Enteric-Coated | 1996 |
4 other study(ies) available for niacinamide and 6-methyl-n-(1h-tetrazol-5-yl)-2-pyridinecarboxamide
| Article | Year |
|---|---|
Studies on a new antiallergic pyridinecarboxamide TA-5707F and its sodium salt (TA-5707). II. Mechanism of antiallergic action of TA-5707.
Topics: Animals; Capillary Permeability; Histamine; Histamine H1 Antagonists; Histamine Release; Lung; Male; Mast Cells; Niacinamide; p-Methoxy-N-methylphenethylamine; Passive Cutaneous Anaphylaxis; Rats; Rats, Inbred Strains; Regional Blood Flow; Skin | 1987 |
Studies on a new antiallergic pyridinecarboxamide TA-5707F and its sodium salt (TA-5707). I. Inhibition of IgE-induced passive cutaneous anaphylaxis (PCA) in rats.
Topics: Adrenal Medulla; Adrenalectomy; Animals; Antigens, Helminth; Ascaris; Dose-Response Relationship, Drug; Immunoglobulin E; Male; Niacinamide; Passive Cutaneous Anaphylaxis; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Antiallergic agents. 3. N-(1H-tetrazol-5-yl)-2-pyridinecarboxamides.
Topics: Animals; Biological Assay; Chemical Phenomena; Chemistry; Hypersensitivity; Niacinamide; Passive Cutaneous Anaphylaxis; Rats; Structure-Activity Relationship | 1984 |
Preparation of controlled release tablets of TA-5707F with wax matrix type and their in vivo evaluation in beagle dogs.
Topics: Animals; Biological Availability; Chemical Phenomena; Chemistry, Physical; Cholinergic Antagonists; Delayed-Action Preparations; Dogs; Drug Interactions; Food-Drug Interactions; Hardness Tests; Histamine H1 Antagonists; In Vitro Techniques; Male; Niacinamide; Solubility; Tablets; Waxes | 1995 |